Treatment Outcomes of Novel Targeted Agents in Relapse/Refractory Chronic Lymphocytic Leukemia: A Systematic Review and Network Meta-Analysis

Most chronic lymphocytic leukemia patients experience a relapse or become refractory to treatment with conventional chemotherapeutic agents. The network meta-analysis assesses the relative efficacy of novel targeted agents for the treatment of a relapse or refractory chronic lymphocytic leukemia. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Po-Huang, Ho, Ching-Liang, Lin, Chin, Wu, Yi-Ying, Huang, Tzu-Chuan, Tu, Yu-Kang, Lee, Cho-Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572611/
https://www.ncbi.nlm.nih.gov/pubmed/31126075
http://dx.doi.org/10.3390/jcm8050737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572611/
https://www.ncbi.nlm.nih.gov/pubmed/31126075
http://dx.doi.org/10.3390/jcm8050737

Ejemplares similares